Surgery Partners
SGRY· Services· Fiscal year ends in December
J. Eric Evans is the CEO of Surgery Partners and was paid $6.1M in FY2025 (Dec), down 6%.
Executives6
See all- 1J. Eric EvansChief Executive OfficerFY2025
- 2Jennifer B. BaldockExecutive Vice President, Chief Administrative and Development OfficerFY2022
- 3Harrison R. BaneFormer President, National GroupFY2024
- 4David T. DohertyExecutive Vice President and Chief Financial OfficerNot disclosed
- 5Marissa A. BrittenhamExecutive Vice President and Chief Strategy OfficerNot disclosed
- 6W. Trent WebbPresident, American GroupNot disclosed
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allSurgery Partners paid CEO J. Eric Evans $6.1M in FY2025 (Dec). No other named executive of that year is on file.
| Name | |||
|---|---|---|---|
| J. Eric EvansChief Executive Officer | Not disclosed | ||
| Jennifer B. BaldockExecutive Vice President, Chief Administrative and Development Officer | Not disclosed | Not disclosed | |
| Harrison R. BaneFormer President, National Group | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers13
See allThe FY2025 (Dec) proxy of Surgery Partners names 13 peer companies for pay. Among Surgery Partners and these peers, CEO pay was the lowest of 6 and total shareholder return was 5th highest of 6.
6th highest of 6in Surgery Partners and its pay peers, FY2025 (Dec) by CEO pay:
5th highest of 6in Surgery Partners and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 23, 2026 | FY2025 |
| Annual report | 10-K | Mar 2, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 24, 2025 | FY2024 |
| Annual report | 10-K | Mar 7, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 25, 2024 | FY2023 |
| Annual report | 10-K | Feb 26, 2024 | FY2023 |